Hot Warren Buffett Stocks To Own For 2019


If you’re looking for good Warren Buffett stocks to buy, there’s no better option than Buffett’s former money guy. I’m talking, of course, about Lou Simpson, the long-time Geico portfolio manager, who retired at the end of 2010 after 31 years at the company, more than a third of them spent under Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B) ownership.

It’s hard to believe that the legendary investment manager, who outperformed the S&P 500 in 18 out of 25 years between 1980 and 2004, has been retired for more than seven years. Boy does time fly.


Simpson grew bored of retirement very quickly, so the veteran money set up SQ Advisors, an investment advisory firm with $200 million in assets under management that would handle money for friends, family and some charities.

Charging 1% annually with no performance fees, Simpson was just happy to have something to do every day that he enjoyed and could help people. Fast forward to the end of 2017 and Simpson’s managing $3.1 billion in assets invested in just 14 stocks.

Hot Warren Buffett Stocks To Own For 2019: Zynga Inc.(ZNGA)


Advisors’ Opinion:

  • [By Chris Lange]

    Zynga Inc. (NASDAQ: ZNGA) shares made a small gain on Wednesday after Wedbush said that it can see this stock making about a 50% run over the next year and that a turnaround is underway.

  • [By Shane Hupp]

    Zynga (NASDAQ: ZNGA) and iPass (NASDAQ:IPAS) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Zynga (ZNGA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Zynga (ZNGA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    This is a very aggressive tech play that could have upside above the current price targets. Zynga Inc. (NASDAQ: ZNGA) is a leading developer of mobile and social games. In the company’s relatively short history, it has developed a broad portfolio of games that includes several games on Facebook and several top-grossing mobile apps. Key franchises include FarmVille, Zynga Poker, Hit It Rich Slots and Words With Friends.

  • [By Shane Hupp]

    Zynga (NASDAQ: ZNGA) is one of 61 publicly-traded companies in the “Data processing & preparation” industry, but how does it weigh in compared to its rivals? We will compare Zynga to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, institutional ownership, risk and profitability.

Hot Warren Buffett Stocks To Own For 2019: Discovery Communications, Inc.(DISCA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DISCOVERY COMMUNICATIONS INC. Common Stock (DISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Stephan Byrd]

    BidaskClub upgraded shares of DISCOVERY COMMUNICATIONS INC. Common Stock (NASDAQ:DISCA) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday.

  • [By Billy Duberstein]

    You might thinkDiscovery Inc.’s (NASDAQ:DISCA) (NASDAQ:DISCK) (NASDAQ:DISCB) stations primarily feature nature videos and celebrity cooks, but did you know it’s actually becoming a player on the international sports scene? While known for its namesake Discovery Channel and documentary brands such as The Learning Channel, HGTV, and the Food Network, Discovery has actually been in the sports business since 2012, when it first acquired a minority stake in European sports channel Eurosport. Discovery was apparently pleased enough with the channel’s progress to buy 100% of Eurosport in July 2015, and that year, Eurosport won the exclusive rights to broadcast the Olympics in Europe from 2018-2022.

Hot Warren Buffett Stocks To Own For 2019: XTL Biopharmaceuticals Ltd.(XTLB)


Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

Hot Warren Buffett Stocks To Own For 2019: Energizer Holdings, Inc.(ENR)


Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:

Hot Warren Buffett Stocks To Own For 2019: Skechers U.S.A., Inc.(SKX)


Advisors’ Opinion:

  • [By Todd Campbell and Timothy Green]

    Buying and holding shares in great companies like eBayfor the long haul has proven to be very profit-friendly, but identifying growth stocks early on isn’t easy. To help find tomorrow’s winners, we asked two Motley Fool investors which burgeoning growth stocks are on their radar right now. They responded with Skechers (NYSE:SKX)and Mimecast (NASDAQ:MIME). Read on to find out if these stocks deserve a spot in your portfolio.

  • [By Matthew Cochrane]

    Now that we’ve defined value investing, highlighted a few metrics that value investors look for, and warned investors to watch out for value traps, let’s take a closer look at stocks that I believe are trading at prices below their intrinsic value today. While representing very different industries, the one thing that AFLAC Incorporated (NYSE:AFL), Skechers USA Inc (NYSE:SKX), and Verizon Communications Inc (NYSE:VZ) all have in common is that, based on each company’s fundamentals, they appear to be some of the best bargainsavailable in the stock market today.

  • [By ]

    A Growth Stock Masquerading As A Value Stock
    Skechers (NYSE: SKX): is the fast growing footwear company located in Manhattan Beach, California. The company is riding a huge secular trend of international growth fueled principally by growth in India and China.

  • [By ]

    Skechers USA (SKX) : “I think they’re doing well. I think it’s really good and they’ve done a good job.”

    Kratos Defense & Security (KTOS) : “This one is a battleground and I don’t want to be there.”

  • [By Chris Lange]

    When Skechers USA Inc. (NYSE: SKX) reported its most recent quarterly results after the markets closed on Thursday, the company said that it had $0.75 in earnings per share (EPS) on $1.25 billion in revenue. The consensus estimates had called for $0.75 in EPS on revenue of $1.2 billion. The first quarter of last year reportedly had EPS of $0.60and $1.07 billion in revenue.

Hot Warren Buffett Stocks To Own For 2019: Celgene Corporation(CELG)

Advisors’ Opinion:

  • [By Paul Ausick]

    Celgene Corp. (NASDAQ: CELG) dropped about 5.6% Monday to post a new 52-week low of $74.13. Shares closed at $78.37 on Friday and the stock’s 52-week high is $147.17. Volume of around 16.3 million shares was more than double the daily average.The company was one of several named last week in an FDA report of drugmakers who may be illegally blocking delaying access to cheaper generic copies of brand-name drugs. Then today, word got out that the firm’s chief business development officer had retired in April.

  • [By ]

    First up, Celgene Corp. (NADSAQ:CELG) plunked down $9 billion to acquire Juno Therapeutics (NASDAQ:JUNO) and get ahold of its promising line of CAR-T cancer treatments. The announcement juiced JUNO shares by more than 25% on the day, bringing its five day gains to an eye-popping 75%.

  • [By Cory Renauer]

    Biotech traders get heaps of attention, but buying promising young drugmakers and holding them for the long term is a far easier way to get rich. Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB),Celgene Corporation (NASDAQ:CELG), andGilead Sciences Inc.(NASDAQ:GILD) around this time in 1998 would have made you a millionaire already.

  • [By Logan Wallace]

    Investors sold shares of Celgene (NASDAQ:CELG) on strength during trading hours on Friday. $125.14 million flowed into the stock on the tick-up and $200.18 million flowed out of the stock on the tick-down, for a money net flow of $75.04 million out of the stock. Of all stocks tracked, Celgene had the 12th highest net out-flow for the day. Celgene traded up $2.16 for the day and closed at $84.54

  • [By Keith Speights]

    Celgene (NASDAQ:CELG) claims the best-selling orphan drug of 2017 with Revlimid. The blood cancer drug raked in over $5.5 billion in U.S. sales last year and generated another $2.8 billion outside of the U.S.While U.S. sales grew nearly 23% year over year, most of the increase stemmed from price increases. Celgene has been criticized by the U.S. Food and Drug Administration (FDA) for the steep price hikes for Revlimid.

  • [By Keith Speights]

    What’s the riskiest big biotech stock on the market? According to market research firm EvaluatePharma, it’sCelgene (NASDAQ:CELG).

    Many investors have been very bearish about Celgene for months. The company’s once-promising Crohn’s disease drug GED-0301 flopped miserably in a late-stage clinical study in October 2017. Celgene thoroughly embarrassed itself, with the FDA refusing to review the regulatory submission of ozanimod in treating multiple sclerosis (MS). Largely because of these major setbacks, Celgene stock has plunged 45% over the last eight and a half months.